MFDS — authorised 31 December 2012
- Marketing authorisation holder: SALIX PHARMS
- Status: likely_approved
🇰🇷 Mytesi in South Korea
MFDS authorised Mytesi on 31 December 2012
Marketing authorisation
Mytesi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Mytesi approved in South Korea?
Yes. MFDS authorised it on 31 December 2012.
Who is the marketing authorisation holder for Mytesi in South Korea?
SALIX PHARMS holds the South Korean marketing authorisation.